This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care Winners & Losers: Alkermes

The analyst assigned the highest scores to biotechnology companies including Alkermes (ALKS - Get Report), EnteroMedics (ETRM - Get Report), Volcano (VOLC), Emergent Biosolutions (EBS - Get Report) and Gilead Sciences (GILD - Get Report)

His lowest scores went to research and development services company Charles River Laboratories International (CRL - Get Report), radiation equipment maker Accuray (ARAY - Get Report), medical device maker Kinetic Concepts (KCI), PDL BioPharma (PDLI - Get Report) and testing systems maker Waters (WAT).

With the markets moving lower in midday trading, Alkermes shares closed down 91 cents, or 8.4%, to $9.97, and Gilead Sciences shares lost $1.08 to $47.20. Shares of Charles River Labs fell 87 cents to $25.51, and stock in Accuray gave up 43 cents, or 8%, to $4.96. Trading volume was mostly light.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALKS $39.75 -3.73%
ARAY $5.36 0.00%
CRL $79.27 -0.95%
EBS $38.52 -1.73%
ETRM $0.79 -5.67%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs